Torrent Pharmaceuticals Limited (BOM:500420)

Torrent Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	21,634	19,113	16,564	12,452	7,772
Depreciation & Amortization	11,042	7,740	7,748	6,830	6,427
Other Amortization	145.1	209.3	204.6	190.3	192.8
Loss (Gain) From Sale of Assets	-176.6	-13.4	-883.6	-216.2	8.2
Asset Writedown & Restructuring Costs	1.7	-	129.7	45.6	2.3
Loss (Gain) From Sale of Investments	-316.7	-167.3	-179.9	-195.1	-101.4
Provision & Write-off of Bad Debts	55.4	17.7	70.8	22.7	9
Other Operating Activities	1,262	3,762	4,826	4,734	7,239
Change in Accounts Receivable	-2,539	171.7	783.2	-2,897	-1,091
Change in Inventory	343.8	-2,622	-494.3	2,557	2,189
Change in Accounts Payable	1,641	-2,777	4,136	-580.2	-3,924
Change in Other Net Operating Assets	-2,865	418.1	-243.6	738.3	-692.5
Operating Cash Flow	30,227	25,851	32,661	23,681	18,030
Operating Cash Flow Growth	16.93%	-20.85%	37.92%	31.34%	-10.09%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-6,774	-6,119	-4,328	-5,739	-2,026
Sale of Property, Plant & Equipment	409.5	177.7	1,337	1,587	67.9
Cash Acquisitions	-123,150	-	-	-20,000	-
Investment in Securities	2,028	337.9	1,181	-129.8	-80.9
Other Investing Activities	361.4	202.6	131.2	129	72.4
Investing Cash Flow	-127,124	-5,401	-1,679	-24,153	-1,966

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	16,041	-	-	8,420	2,186
Long-Term Debt Issued	109,900	-	-	13,950	-
Total Debt Issued	125,941	-	-	22,370	2,186
Short-Term Debt Repaid	-	-3,963	-1,334	-	-
Long-Term Debt Repaid	-7,271	-5,564	-12,599	-9,936	-10,651
Total Debt Repaid	-7,271	-9,527	-13,933	-9,936	-10,651
Net Debt Issued (Repaid)	118,670	-9,527	-13,933	12,434	-8,464
Common Dividends Paid	-12,889	-10,830	-10,153	-5,132	-6,769
Other Financing Activities	-4,275	-2,622	-3,710	-3,030	-2,577
Financing Cash Flow	101,506	-22,980	-27,796	773.6	-17,811

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Foreign Exchange Rate Adjustments	828.2	-87.3	80.7	211.2	5.3
Miscellaneous Cash Flow Adjustments	-	-	-	588.3	-
Net Cash Flow	5,437	-2,617	3,266	1,101	-1,742

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	23,453	19,732	28,333	17,942	16,004
Free Cash Flow Growth	18.86%	-30.35%	57.92%	12.11%	-4.18%
Free Cash Flow Margin	16.78%	17.14%	26.41%	18.65%	18.81%
Free Cash Flow Per Share	69.30	58.30	83.72	53.01	47.29
Levered Free Cash Flow	26,012	12,787	22,213	14,783	10,209
Unlevered Free Cash Flow	28,417	14,358	24,417	16,860	11,790

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	4,275	2,622	3,710	3,030	2,577
Cash Income Tax Paid	8,089	6,028	4,981	3,981	4,210
Change in Working Capital	-3,420	-4,809	4,181	-182	-3,519

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error